RCE 4.62% 62.0¢ recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-104

  1. 5,232 Posts.
    lightbulb Created with Sketch. 679
    I meant "maybe Fiona Stanley are so impressed with phase 2 they will push for next phase asap due to unmet need."

    It would also be valuable I think if Recce refer directly to the QIDP and or FDA regarding future progress or plans at some stage.

    Hard to believe they just plan to sell this product in Australia but would be good to get official confirmation FDA is a target for either or both IV and burns? At this stage there still appear to be some who think they have decided against this path.
    I'm looking forward to seeing where this goes .
    Last edited by andrewk65: 07/01/22
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
62.0¢
Change
-0.030(4.62%)
Mkt cap ! $127.4M
Open High Low Value Volume
65.0¢ 65.5¢ 61.5¢ $78.93K 125.3K

Buyers (Bids)

No. Vol. Price($)
2 9703 61.5¢
 

Sellers (Offers)

Price($) Vol. No.
64.0¢ 50000 1
View Market Depth
Last trade - 16.10pm 14/05/2024 (20 minute delay) ?
Last
64.0¢
  Change
-0.030 ( 1.54 %)
Open High Low Volume
65.5¢ 65.5¢ 64.0¢ 4035
Last updated 14.23pm 14/05/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.